Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Bio Essence (BIOE) Gross Profit (2020 - 2025)

Bio Essence has reported Gross Profit over the past 6 years, most recently at $1.1 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 969.64% year-over-year to $1.1 million; the TTM value through Dec 2025 reached $1.4 million, up 385.28%, while the annual FY2025 figure was $1.4 million, 558.02% up from the prior year.
  • Gross Profit for Q4 2025 was $1.1 million at Bio Essence, up from $95760.0 in the prior quarter.
  • Over five years, Gross Profit peaked at $1.1 million in Q4 2025 and troughed at -$23522.0 in Q4 2023.
  • A 5-year average of $131343.0 and a median of $79132.5 in 2024 define the central range for Gross Profit.
  • Biggest five-year swings in Gross Profit: crashed 267.83% in 2023 and later soared 969.64% in 2025.
  • Year by year, Gross Profit stood at $61724.0 in 2021, then plummeted by 77.29% to $14015.0 in 2022, then crashed by 267.83% to -$23522.0 in 2023, then surged by 554.46% to $106898.0 in 2024, then soared by 969.64% to $1.1 million in 2025.
  • Business Quant data shows Gross Profit for BIOE at $1.1 million in Q4 2025, $95760.0 in Q3 2025, and $168644.0 in Q2 2025.